BEVACIZUMAB, DOXORUBICIN, AND CYCLOPHOSPHAMIDE FOLLOWED BY PACLITAXEL ALBUMIN-STABILIZED NANOPARTICLE FORMULATION AND BEVACIZUMAB IN TREATING PATIENTS WHO HAVE UNDERGONE SURGERY FOR EARLY-STAGE BREAST CANCER: